Metamelfalan

Metamelfalan

SCHEMBL6842568

N[C@H](Cc1cccc(N(CCCl)CCCl)c1)C(=O)O

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.70
▸ ALOX15 P16050 3/20 0.70
▸ HIF1A Q16665 3/20 0.70
▸ PTGS1 P23219 3/20 0.70
▸ ALDH1A1 P00352 2/20 0.70
▸ SMN1; SMN2 Q16637 2/20 0.70
▸ TDP1 Q9NUW8 2/20 0.70
▸ KDM4E B2RXH2 2/20 0.70
▸ LMNA P02545 2/20 0.70
▸ ABCB11 O95342 1/20 0.70
▸ CHRM2 P08172 1/20 0.70
▸ ADRA2A P08913 1/20 0.70
▸ CHRM1 P11229 1/20 0.70
▸ ACHE P22303 1/20 0.70
▸ OPRM1 P35372 1/20 0.70
▸ DRD3 P35462 1/20 0.70
▸ SLC6A3 Q01959 1/20 0.70
▸ KCNH2 Q12809 1/20 0.70
▸ CYP1A2 P05177 1/20 0.70
▸ NFKB1 P19838 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Metamelfalan SCHEMBL30781236 1.00 CYP3A4 (0.70) CYP3A4ALOX15HIF1APTGS1ALDH1A1
Metamelfalan SCHEMBL2015272 1.00 CYP3A4 (0.70) CYP3A4ALOX15HIF1APTGS1ALDH1A1
Metamelfalan SCHEMBL2015275 1.00 CYP3A4 (0.70) CYP3A4ALOX15HIF1APTGS1ALDH1A1
Melphalan SCHEMBL4984726 0.84 HIF1A (0.91) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL18427979 0.84 IDO1 (0.57) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL19714971 0.84 IDO1 (0.57) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL18427948 0.84 IDO1 (0.57) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL6843476 0.83 SMN1; SMN2 (0.53) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL2778981 0.83 NOS3 (0.56) CYP3A4ALOX15HIF1APTGS1ALDH1A1
SCHEMBL2778977 0.83 NOS3 (0.56) CYP3A4ALOX15HIF1APTGS1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6767992-B1 USED FOR CHEMOTHERAPY AGAINST CANCERS AND IS USED ESPECIALLY FOR MELANOMAS PTC PHARMA AG (CH) 2004-07-27 — — US disclosed
Send feedback